In this article, we will be taking a look at the 8 gene-editing stocks to buy. Gene editing is an advanced medical technique within gene therapy that involves precisely modifying an individual’s ...
Knocking out a single gene reprograms part of the large intestine to function like the nutrient-absorbing small intestine. In ...
At meeting on human embryo editing, CRISPR pioneer says science is a long way from knowing if germline DNA can be safely ...
Controversial figure stands by a research approach that landed him in prison as he aims to tackle Alzheimer’s disease.
Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...
As other gene editing programs fold or get sold, Arbor Biotechnologies has secured $73.9 million to advance its lead liver-targeting gene therapy into human trials. The series C was led by Arch ...
What’s really exciting about gene editing is precision and speed, says Pairwise cofounder and CEO Tom Adams, PhD.
It's early days for xenotransplantation, but eGenesis, Eledon, United Therapeutics and more are working to develop solutions to make this approach a viable option and help ease the organ shortage ...
Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...
The gene-editing field may have yet another legal squabble on its hands — this time between two companies created by the same star biotech researcher, in a dispute that gets at the core of some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback